$8.690
-0.526 (-6.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
IMMX Prediction & Forecast by Similar Chart Analysis
Alphio's IMMX stock price prediction model matches the current Immix Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.67 (+1.88%). The 1-week path is $8.48 (-0.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Immix Biopharma Inc Stock?
Immix Biopharma Inc is a good buy right now due to its promising clinical trial results for NXC-201, which showed an 89% complete response rate, and a significant price target increase from analysts, with BofA setting it at $30, indicating over 190% upside potential from the current price of $9.46. However, the stock has experienced a 22.08% decline over the last 20 days, which presents a risk to consider.
IMMX stock price ended at $8.69 on Tuesday, after losing -6.05%
Immix Biopharma Inc (IMMX) last closed at $8.51, losing -2.07%. These facts feed the 1-day and 1-week IMMX price prediction above.
Forecast Drivers
Immix Biopharma Inc (IMMX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches IMMX, ranked by similarity.
Seasonality analysis for IMMX
Historically the probability of a positive October return for IMMX is 54.39%. July offers the highest probability of a positive month at 65.15%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for IMMX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $2.39 | $2.88 | $3.04 | -66.13% |
| Nov 2026 | $2.93 | $3.14 | $3.46 | -63.13% |
| Dec 2026 | $2.22 | $2.79 | $3.24 | -67.27% |
In 2026, Immix Biopharma Inc (IMMX) is projected to range from $2.22 to $3.46.
Immix Biopharma Inc 2026 monthly forecast
In Oct 2026, Immix Biopharma Inc is projected to average $2.88, with a low of $2.39 and high of $3.04.
In Nov 2026, Immix Biopharma Inc is projected to average $3.14, with a low of $2.93 and high of $3.46.
In Dec 2026, Immix Biopharma Inc is projected to average $2.79, with a low of $2.22 and high of $3.24.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.